Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) Other financing activities (2016 - 2020)

Sonoma Pharmaceuticals has reported Other financing activities over the past 9 years, most recently at $90000.0 for Q4 2020.

  • For Q4 2020, Other financing activities rose 114.29% year-over-year to $90000.0; the TTM value through Dec 2020 reached $52000.0, down 7.14%, while the annual FY2020 figure was $50000.0, 261.29% up from the prior year.
  • Other financing activities for Q4 2020 was $90000.0 at Sonoma Pharmaceuticals, up from -$34000.0 in the prior quarter.
  • Over five years, Other financing activities peaked at $90000.0 in Q4 2020 and troughed at -$50000.0 in Q3 2018.
  • A 5-year average of $2800.0 and a median of $2000.0 in 2016 define the central range for Other financing activities.
  • Biggest five-year swings in Other financing activities: plummeted 650.0% in 2016 and later soared 4100.0% in 2019.
  • Year by year, Other financing activities stood at -$22000.0 in 2016, then skyrocketed by 95.45% to -$1000.0 in 2017, then surged by 200.0% to $1000.0 in 2018, then soared by 4100.0% to $42000.0 in 2019, then surged by 114.29% to $90000.0 in 2020.
  • Business Quant data shows Other financing activities for SNOA at $90000.0 in Q4 2020, -$34000.0 in Q3 2020, and -$4000.0 in Q2 2020.